Establishment of a novel human lymphoblastic cell strain with the long arm of chromosome 11 aberration without MLL rearrangement

• Main Authors: Qian Wang, Lin Zhuang, Pei Li, Qiang Niu, Ping Zhu, Miao-Xia He, Hui Jiang, Chang-Cheng Liu, Min-Jun Wang, Li Chen, Hui Cheng, Yan Ma, Xiao-Xia Hu, Yi-Ping Hu, Xiao-Ping Xu
• Format: Article
• Language: English
• Published: Nature Publishing Group 2017-04-01
• Series: Scientific Reports
• Online Access: https://doi.org/10.1038/s41598-017-00874-6

Abstract At present, all cell strains derived from acute lymphoblastic leukemia (ALL) patients with the long arm of chromosome 11 aberration are accompanied with mixed lineage leukemia (MLL) gene rearrangement. In this study, we established a permanent ALL cell strain CHH-1 with the long arm of chromosome 11 aberration and without MLL rearrangement, hoping that it could be used for the research of ALL with such genetic abnormality. CHH-1 cell strain was certified through morphology, immunophenotype, genetics and immunoglobulin (Ig) gene rearrangement analysis. Cell characteristics including tumorigenic ability, semisolid colony forming ability, telomerase activity, autocrine and invasion were further detected. Cells were with an add(11)(q23) structural abnormality without MLL rearrangement, and were consistent with the genetic abnormality of the patient. In addition, these cells had features of tumor-forming ability, high colony forming capacity, unique cytokine autocrine mode, high telomerase activity, and high invasion ability. CHH-1 may prove to be a useful cell model for the research of human leukemia with genetic aberration in chromosome 11, and help explore the role of such genetic abnormality in the pathogenesis, progression and prognosis of ALL, and in developing new target drugs.